The FDA says the Zepbound shortage is over. It's rattling the weight loss industry
The U.S. Food and Drug Administration announced Thursday that the shortage of tirzepatide—the active ingredient in Eli ...
The National Law Review18h
FDA Targets GLP-1 Providers with Warning Letters
On December 17, the U.S. Food and Drug Administration (FDA) issued Warning Letters to five companies offering various GLP-1 ...